A Phase I trial of JHL1149 in China

Trial Profile

A Phase I trial of JHL1149 in China

Phase of Trial: Phase I

Latest Information Update: 07 Mar 2018

At a glance

  • Drugs Bevacizumab (Primary)
  • Indications Solid tumours
  • Focus Pharmacokinetics
  • Most Recent Events

    • 07 Mar 2018 New trial record
    • 01 Mar 2018 According to a JHL Biotech media release, this trial is expected to be conducted in 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top